Fact CheckerSign in

NCT07684768Completed

IMPACT OF CARDIAC AUTONOMIC NEUROPATHY ON QT AND QTC INTERVAL

IMPACT OF CARDIAC AUTONOMIC NEUROPATHY ON QT AND QTC INTERVAL IN PATIENTS SCHEDULED FOR CORONARY ARTERY BYPASS GRAFTING

Source: ClinicalTrials.gov · Last updated 6 Jul 2026

Brief summary (registry, in English)

This prospective observational cohort study evaluated the effect of cardiac autonomic neuropathy (CAN) on perioperative ventricular repolarization, specifically QT and corrected QT (QTc) intervals, in patients undergoing elective coronary artery bypass grafting (CABG) surgery under general anesthesia. The study was conducted in a tertiary care university hospital between October 2023 and December 2024. Adult patients scheduled for isolated elective CABG surgery with sinus rhythm on preoperative electrocardiography were screened for eligibility. Cardiac autonomic function was assessed preoperatively using standardized Ewing's cardiovascular reflex tests. Patients were classified into two groups according to test results: CAN-positive (≥2 abnormal tests) and CAN-negative (\<2 abnormal tests). QT and QTc intervals were measured at predefined perioperative time points, including before anesthesia induction, baseline, before intubation, at 1 and 30 minutes after intubation, before cannulation, and 24 hours postoperatively. The primary objective was to compare perioperative QT and QTc interval changes between patients with and without CAN. Secondary outcomes included QT and QTc variability (ΔQT, ΔQTc) and the incidence of clinically significant QTc prolongation.

Status (registry)
Completed
Study type
Observational
Enrollment
60 (actual)
First submitted
29 Jun 2026
Start date
5 Oct 2023
Primary completion date
20 Dec 2024
Lead sponsor
Haseki Training and Research Hospital
NCT number
NCT07684768

What you commit to

  • Study type: Observational
  • Participants enrolled: 60
  • From 5 Oct 2023 to the primary completion date, 20 Dec 2024
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous cardiac surgery.

Other illness

  • Atrial fibrillation or other clinically significant cardiac arrhythmias.

Lab values

  • Congenital long QT syndrome.

Other

  • Emergency CABG.
  • Permanent pacemaker implantation.
  • Bundle branch block.

Who the study is looking for

  • Age ≥18 years.
  • Scheduled for elective isolated coronary artery bypass grafting (CABG).
  • Sinus rhythm on preoperative 12-lead electrocardiography.
  • Ability to undergo preoperative cardiovascular autonomic function assessment using Ewing's cardiovascular reflex tests.
  • Written informed consent provided.

Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Health Science University, Haseki Training and Research Hospital
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status
Sultangazi Haseki Training and Research Hospital
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.